Home › Focal Segmental Glomerulosclerosis › South Carolina
Focal Segmental Glomerulosclerosis clinical trials in South Carolina
6 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in South Carolina.
Cities in South Carolina
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #23, Goose Creek
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Palmetto Nephrology, Orangeburg
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 30, 2026 · NCT07220083Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Medical University of South Carolina Children's Hospital, Charleston
- Medical University of South Carolina, Charleston
Recruiting
Up to age 75 · All sexes · Updated Aug 28, 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Medical University of South Carolina Children's Hospital, Charleston
Recruiting
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT02235857Nephrotic Syndrome Study Network
- Medical University of South Carolina, Charleston
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000NEPTUNE Match Study
- Medical University of South Carolina, Charlotte
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.